scispace - formally typeset
Open AccessJournal ArticleDOI

Interpretative strategies for lung function tests

Reads0
Chats0
TLDR
This section is written to provide guidance in interpreting pulmonary function tests (PFTs) to medical directors of hospital-based laboratories that perform PFTs, and physicians who are responsible for interpreting the results of PFTS most commonly ordered for clinical purposes.
Abstract
SERIES “ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING” Edited by V. Brusasco, R. Crapo and G. Viegi Number 5 in this Series This section is written to provide guidance in interpreting pulmonary function tests (PFTs) to medical directors of hospital-based laboratories that perform PFTs, and physicians who are responsible for interpreting the results of PFTs most commonly ordered for clinical purposes. Specifically, this section addresses the interpretation of spirometry, bronchodilator response, carbon monoxide diffusing capacity ( D L,CO) and lung volumes. The sources of variation in lung function testing and technical aspects of spirometry, lung volume measurements and D L,CO measurement have been considered in other documents published in this series of Task Force reports 1–4 and in the American Thoracic Society (ATS) interpretative strategies document 5. An interpretation begins with a review and comment on test quality. Tests that are less than optimal may still contain useful information, but interpreters should identify the problems and the direction and magnitude of the potential errors. Omitting the quality review and relying only on numerical results for clinical decision making is a common mistake, which is more easily made by those who are dependent upon computer interpretations. Once quality has been assured, the next steps involve a series of comparisons 6 that include comparisons of test results with reference values based on healthy subjects 5, comparisons with known disease or abnormal physiological patterns ( i.e. obstruction and restriction), and comparisons with self, a rather formal term for evaluating change in an individual patient. A final step in the lung function report is to answer the clinical question that prompted the test. Poor choices made during these preparatory steps increase the risk of misclassification, i.e. a falsely negative or falsely positive interpretation for a lung function abnormality or a change …

read more

Citations
More filters
Journal ArticleDOI

Standardisation of spirometry

TL;DR: This research presents a novel and scalable approach called “Standardation of LUNG FUNCTION TESTing” that combines “situational awareness” and “machine learning” to solve the challenge of integrating nanofiltration into the energy system.
Journal ArticleDOI

Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations

TL;DR: Spirometric prediction equations for the 3–95-age range are now available that include appropriate age-dependent lower limits of normal for spirometric indices, which can be applied globally to different ethnic groups.
References
More filters
Journal ArticleDOI

Prognosis in chronic obstructive pulmonary disease.

TL;DR: Patients with low initial values of FEV1 showed relatively little further decline, probably indicating a survivor effect, and mortality in the present series was less than that of a previous series, and the same as that of hypoxemic patients with COPD who received continuous home O2 therapy.
Book

Guides to the evaluation of permanent impairment

TL;DR: The material in the fifth edition is scientifically and consensus based, and is prepared by society experts, and includes significant improvements in major chapters including cardiology, respiratory, muscular-skeletal, and skin.
Journal ArticleDOI

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

TL;DR: Evaluated changes in clinical and physiological variables over time for survival time in 81 patients with biopsy-proven idiopathic pulmonary fibrosis found that changes in dyspnea score, total lung capacity, FVC, partial pressure of arterial oxygen, oxygen saturation, and alveolar-arterial oxygen gradient were predictive of survival time after adjustment for baseline values.
Journal ArticleDOI

Standardization of the measurement of transfer factor (diffusing capacity)

TL;DR: The structural dimensions include the lung volume, the path length for diffusion in the gas phase, the thickness and area of the alveolar capillary membrane including any effects of airway closure, and the volume of blood in capillaries supplying alveoli which are ventilated.
Related Papers (5)